Adult Stem Cells Approved for ALS Clinical Trial
The U.S. FDA has granted approval to Neuralstem for testing of its adult stem cell product in a clinical trial for ALS.
September 21, 2009
The U.S. FDA has granted approval to Neuralstem for testing of its adult stem cell product in a clinical trial for ALS.
The U.S. adult stem cell company Bioheart has announced positive results from its clinical trial in the treatment of heart failure with adult stem cells.
Scientists at the Scripps Research Institute have successfully reversed a rare genetic disorder with autologous adult stem cell therapy.
Fluidigm has announced the design of an "integrated fluidic circuit" chip for the culturing of stem cells.
Among this year’s recipients of the Lasker Awards are Dr. Shinya Yamanaka of Kyoto University in Japan and Dr. John Gurdon of Cambridge University in England.
The U.S. company Stem Cell Therapy International and the S. Korean company Histostem today announced the terms of a litigation settlement.